These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9162201)

  • 1. Different cytogenetic patterns in skeletal breast cancer metastases.
    Adeyinka A; Pandis N; Nilsson J; Idvall I; Mertens F; Petersson C; Heim S; Mitelman F
    Genes Chromosomes Cancer; 1996 May; 16(1):72-4. PubMed ID: 9162201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer.
    Teixeira MR; Pandis N; Bardi G; Andersen JA; Heim S
    Cancer Res; 1996 Feb; 56(4):855-9. PubMed ID: 8631024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients.
    Pandis N; Teixeira MR; Adeyinka A; Rizou H; Bardi G; Mertens F; Andersen JA; Bondeson L; Sfikas K; Qvist H; Apostolikas N; Mitelman F; Heim S
    Genes Chromosomes Cancer; 1998 Jun; 22(2):122-9. PubMed ID: 9598799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
    Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
    Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytogenetic findings in ductal carcinoma of the breast].
    Rojas-Atencio A; González L; Urdaneta K; Soto-Alvarez M; Prieto-Carrasquero M; Fulcado W; Quintero M; Boscán A; Alvarez Nava F
    Invest Clin; 1999 Sep; 40(3):179-89. PubMed ID: 10531751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare clonal karyotypic variants in primary cultures of human breast carcinoma cells.
    Zhang R; Wiley J; Howard SP; Meisner LF; Gould MN
    Cancer Res; 1989 Jan; 49(2):444-9. PubMed ID: 2910462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A polymorphism in the G protein beta3-subunit gene is associated with bone metastasis risk in breast cancer patients.
    Clar H; Langsenlehner U; Krippl P; Renner W; Leithner A; Gruber G; Hofmann G; Yazdani-Biuki B; Langsenlehner T; Windhager R
    Breast Cancer Res Treat; 2008 Oct; 111(3):449-52. PubMed ID: 17978878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping.
    Stark B; Jeison M; Bar-Am I; Glaser-Gabay L; Mardoukh J; Luria D; Feinmesser M; Goshen Y; Stein J; Abramov A; Zaizov R; Yaniv I
    Genes Chromosomes Cancer; 2002 Jul; 34(3):313-24. PubMed ID: 12007192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
    Martínez-Climent JA; Comes AM; Vizcarra E; Benet I; Arbona C; Prósper F; Solano C; García Clavel B; Marugán I; Lluch A; García-Conde J
    Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cytogenetic characterization of human breast cancer cell line MDA-MB-468 and its variant 468LN, which displays aggressive lymphatic metastasis.
    Xu J; Chambers AF; Tuck AB; Rodenhiser DI
    Cancer Genet Cytogenet; 2008 Feb; 181(1):1-7. PubMed ID: 18262045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recurring pattern of chromosomal aberrations in mammary gland tumors of MMTV-cmyc transgenic mice.
    Weaver ZA; McCormack SJ; Liyanage M; du Manoir S; Coleman A; Schröck E; Dickson RB; Ried T
    Genes Chromosomes Cancer; 1999 Jul; 25(3):251-60. PubMed ID: 10379871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone metastasis in breast carcinoma].
    Kölbl O; Kiricuta IC; Willner J; Flentje M
    Zentralbl Chir; 1997; 122(2):97-102. PubMed ID: 9173765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
    Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases.
    Zhao Y; Bachelier R; Treilleux I; Pujuguet P; Peyruchaud O; Baron R; Clément-Lacroix P; Clézardin P
    Cancer Res; 2007 Jun; 67(12):5821-30. PubMed ID: 17575150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
    Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
    Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha CTX as a biomarker of skeletal invasion of breast cancer: immunolocalization and the load dependency of urinary excretion.
    Leeming DJ; Delling G; Koizumi M; Henriksen K; Karsdal MA; Li B; Qvist P; Tankó LB; Byrjalsen I
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1392-5. PubMed ID: 16835341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum tumor markers in skeletal metastasis.
    Tsukushi S; Katagiri H; Kataoka T; Nishida Y; Ishiguro N
    Jpn J Clin Oncol; 2006 Jul; 36(7):439-44. PubMed ID: 16815865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.